Bank Of New York Mellon Corp Anavex Life Sciences Corp. Transaction History

Bank Of New York Mellon Corp

$521 Trillion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$8.32 - $11.75 $2.12 Million - $2.99 Million	254,523 New	254,523 $2.18 Billion
Q4 2022 Feb 14, 2023	BUY	$7.65 - $14.43 $1.9 Million - $3.59 Million	248,474 New	248,474 $2.3 Million
Q3 2022 Nov 14, 2022	BUY	$8.9 - $12.86 $264,961 - $382,855	29,771 Added 13.65%	247,897 $2.56 Million
Q2 2022 Aug 15, 2022	SELL	$7.31 - $12.84 $62,982 - $110,629	-8,616 Reduced 3.8%	218,126 $2.18 Million
Q1 2022 May 11, 2022	BUY	$9.74 - $17.69 $10,041 - $18,238	1,031 Added 0.46%	226,742 $2.79 Million

Q4 2021 Feb 11, 2022	BUY	$16.88 - $23.31 $139,006 - $191,957	8,235 Added 3.79%	225,711 $3.91 Million
Q3 2021 Nov 12, 2021	SELL	$16.82 - $25.75 $734,882 - $1.13 Million	-43,691 Reduced 16.73%	217,476 $3.9 Million
Q2 2021 Aug 11, 2021	BUY	$10.16 - $28.86 $572,455 - $1.63 Million	56,344 Added 27.51%	261,167 $5.97 Million
Q1 2021 May 13, 2021	BUY	$5.17 - $16.13 $55,691 - $173,752	10,772 Added 5.55%	204,823 $3.06 Million
Q4 2020 Feb 09, 2021	BUY	$4.01 - $7.58 $121,354 - $229,393	30,263 Added 18.48%	194,051 $1.05 Million
Q3 2020 Nov 12, 2020	BUY	$3.8 - $5.0 $2,120 - $2,790	558 Added 0.34%	163,788 $745,000
Q2 2020 Aug 12, 2020	BUY	$2.62 - $5.2 $8,300 - $16,473	3,168 Added 1.98%	163,230 $803,000
Q1 2020 May 06, 2020	BUY	$2.38 - $5.81 $42,723 - $104,295	17,951 Added 12.63%	160,062 $504,000
Q4 2019 Feb 14, 2020	BUY	$2.31 - $3.14 $19,239 - $26,153	8,329 Added 6.23%	142,111 $368,000
Q3 2019 Nov 07, 2019	BUY	$2.22 - $3.9 $872 - $1,532	393 Added 0.29%	133,782 $422,000
Q2 2019 Aug 12, 2019	BUY	$2.75 - $3.7 $287,023 - $386,176	104,372 Added 359.69%	133,389 $449,000
Q1 2019 May 14, 2019	SELL	$1.68 - $3.42 $1,412 - $2,876	-841 Reduced 2.82%	29,017 $89,000
Q3 2018 Nov 09, 2018	SELL	$2.23 - $3.82 $2 - $3	-1 Reduced -0.0%	29,858 $0
Q2 2018 Aug 06, 2018	SELL	$2.08 - $4.26 $190,937 - $391,055	-91,797 Reduced 75.46%	29,859 $78,000
Q1 2018 May 15, 2018	SELL	$2.32 - $3.44 $130,574 - $193,610	-56,282 Reduced 31.63%	121,656 $337,000
Q4 2017 Feb 09, 2018	BUY	$3.12 - $4.94 $555,166 - $879,013	177,938	177,938 $573,000

Others Institutions Holding AVXL

# of Institutions

159

Shares Held

31.6M

Call Options Held

910K

Put Options Held

1.35M

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $352M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account